Biological Drug API Manufacturing Services World Industry and Market Predictions 2018-2028 - Visiongain ReportMarket Watch3 days ago
- Market Watch3 days ago
- Market Watch5 days ago
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis PLC, prior to the acquisition of Allergan Inc) is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Allergan, Inc. and Actavis, Inc. Stock Drop Challenge Blames Fiduciaries for Losses
PARSIPPANY, N.J., Jan. 24, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc. today announced that the company has adopted Actavis, Inc. (NYSE: ACT) as its new global name and will today begin trading under a new symbol — ACT — on the New York Stock Exchange. The company first announced its ...
Actavis Pharma, Inc. company research & investing information. Find executives and the latest company news.
In the Matter of Watson Pharmaceuticals Inc., Actavis Inc., Actavis Pharma Holding 4 ehf., and Actavis S..r.l. The FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the ...
Learn about working at Actavis (now Allergan). Join LinkedIn today for free. See who you know at Actavis (now Allergan), leverage your professional network, and get hired.
- related to Actavis Inc